Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating neo-adjuvant treatment in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]
Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating gefitinib with or without chemotherapy in brain metastases from non-small cell lung cancer is ongoing; results not …
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC). [Phase 2]
Phase 2 clinical trial update for Immunopheresis alone or in combination with paclitaxel or atezolizumab in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy [Phase 1, Phase 2]
Phase 1/2 trial investigating neoadjuvant durvalumab (MEDI4736) followed by radical radiotherapy or chemoradiotherapy in non-surgical early …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating sintilimab with docetaxel for non-driver gene mutation metastatic non-small cell lung cancer after standard …
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating fruquintinib with sintilimab and chemotherapy in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study [Phase 2]
Phase II study evaluating sintilimab plus docetaxel for chemotherapy-failure advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: A Prospective Multi-center Phase III Randomized Controlled Trial [Phase 3]
A Phase III randomized controlled trial update is reported for non-small cell lung carcinoma, with status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection [Phase 3]
Phase 3 trial evaluating almonertinib with or without chemotherapy as adjuvant treatment after complete tumor resection in stage II-IIIA non…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant durvalumab alone or with novel agents in resectable early-stage non-small cell lung cancer has…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC [Phase 2]
Phase 2 exploratory study investigating herombopag for chemotherapy-induced thrombocytopenia in non-small cell lung cancer treated with immu…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC [Phase 2]
A Phase 2 trial update investigating a predictive biomarker for the efficacy and safety of combining chemotherapy with tislelizumab in NSCLC…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating crizotinib as neoadjuvant therapy in patients with non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers [Phase 2]
Phase 2 trial evaluating ponatinib in lung cancer patients preselected by predictive biomarkers; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC [Phase 2]
Phase 2 study evaluating durvalumab with tremelimumab, with or without platinum-based chemotherapy, in patients with metastatic non-small ce…
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101) [Phase 1, Phase 2]
Early-phase trial evaluating safety, efficacy, pharmacokinetics, and pharmacodynamics of avelumab in combination with crizotinib or PF-06463…
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation [Phase 2]
Phase 2 trial evaluating icotinib as adjuvant therapy for stage IIA-IIIA EGFR-mutant adenocarcinoma of the lung (non-small cell lung cancer)…
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC [Phase 2]
Phase 2 trial assessing apatinib combined with radiotherapy in brain metastases from driver-gene negative non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy, surgery, and radiation therapy for non-small cell lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC [Phase 2, Phase 3]
Clinical trial comparing alflutinib alone versus alflutinib with chemotherapy in non-small cell lung cancer (NSCLC) across Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases [Phase 2]
Phase 2 trial investigating tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small cell lung cancer with bra…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC [Phase 1, Phase 2]
A clinical trial update for GAIA-102 in advanced and relapse non-small cell lung cancer across Phase 1 and Phase 2 stages; current status is…
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib [Phase 3]
Phase 3 trial comparing XZP-3621 to crizotinib in non-small cell lung cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation [Phase 2]
Phase II clinical trial evaluating HLX208 in advanced non-small cell lung cancer with BRAF V600 mutation.